hydromorphone hydrochloride injection, USP Principal Display Panel

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 1 mg/mL Ampule Label

RL - 4 950

NDC 0409-2552-11
Rx only
1 mL
Single-use ampul

HYDROmorphone HCl
Injection, USP
CII

1 mg/mL

PROTECT FROM LIGHT

Hospira, Inc.,
Lake Forest, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 1 mg/mL Ampule Label

PRINCIPAL DISPLAY PANEL - 1 mg/mL Ampule Box

1 mL 10 Single-use ampuls

NDC 0409-2552-01
Rx only

HYDROmorphone HCl
Injection, USP
1 mg/mL
CII

For Intravenous, Intramuscular, or Subcutaneous Use

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]
PROTECT FROM LIGHT.

Do not use if solution is discolored or contains a precipitate.

Usual Dosage: See insert.

Hospira

PRINCIPAL DISPLAY PANEL - 1 mg/mL Ampule Box

PRINCIPAL DISPLAY PANEL - 2 mg/mL Ampule Label

RL - 4973

Rx only
NDC 0409-3356-11

1 mL Single-use ampul

HYDROmorphone HCl
Injection, USP
CII

2 mg/mL

PROTECT FROM LIGHT

Hospira, Inc.,
Lake Forest, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 2 mg/mL Ampule Label

PRINCIPAL DISPLAY PANEL - 2 mg/mL Ampule Box

1 mL 10 Single-use ampuls

NDC 0409-3356-01
Rx only

HYDROmorphone HCl
Injection, USP
2 mg/mL
CII

For Intravenous, Intramuscular, or Subcutaneous Use

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]
PROTECT FROM LIGHT.

Do not use if solution is discolored or contains a precipitate.

Usual Dosage: See insert.

Hospira

PRINCIPAL DISPLAY PANEL - 2 mg/mL Ampule Box

PRINCIPAL DISPLAY PANEL - 4 mg/mL Ampule Label

RL - 4949

NDC 0409-2540-11
Rx only
1 mL
Single-use ampul

HYDROmorphone HCl
Injection, USP
CII

4 mg/mL

PROTECT FROM LIGHT

Hospira, Inc.,
Lake Forest, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 4 mg/mL Ampule Label

PRINCIPAL DISPLAY PANEL - 4 mg/mL Ampule Box

1 mL 10 Single-use ampuls

NDC 0409-2540-01
Rx only

HYDROmorphone HCl
Injection, USP
4 mg/mL
CII

For Intravenous, Intramuscular, or Subcutaneous Use

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]
PROTECT FROM LIGHT.

Do not use if solution is discolored or contains a precipitate.

Usual Dosage: See insert.

Hospira

PRINCIPAL DISPLAY PANEL - 4 mg/mL Ampule Box

PRINCIPAL DISPLAY PANEL - 2 mg/mL Vial Label

1mL Single-use vial
Rx only
NDC 0409-3365-11

HYDROmorphone HCl
Injection, USP

2 mg/mL
CII

PROTECT FROM LIGHT

Hospira, Inc., Lake Forest, IL 60045 USA
Hospira

RL-6900

PRINCIPAL DISPLAY PANEL - 2 mg/mL Vial Label

PRINCIPAL DISPLAY PANEL - 2 mg/mL Vial Tray

NDC 0409-3365-01
Rx only
1 mL 25 Single-use vials

HYDROmorphone HCl
Injection, USP
2 mg/mL
CII

For Intravenous, Intramuscular, or Subcutaneous Use

Hospira, Inc., Lake Forest, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 2 mg/mL Vial Tray

PRINCIPAL DISPLAY PANEL - 1 mg/mL Cartridge Label

1 mL Single-use Carpuject™
Sterile Cartridge Unit with Luer Lock

NDC 0409-1283-03
Rx only

HYDROmorphone HCl
Injection, USP
1 mg/mL
CII

RL-5555

PROTECT FROM LIGHT

Hospira, Inc., Lake Forest, IL 60045 USA
Hospira

PRINCIPAL DISPLAY PANEL - 1 mg/mL Cartridge Label

PRINCIPAL DISPLAY PANEL - 1 mg/mL Cartridge Box

1 mL
Single-use

NDC 0409-1283-31
Rx only

10 Carpuject™
Sterile Cartridge Units
with Luer Lock

Needle not included

SLIM-PAK™
Tamper Detection Package

HYDROmorphone HCl
Injection, USP
1 mg/mL
CII

For Intravenous,
Intramuscular, or
Subcutaneous Use

Carpuject Cartridges are to be used
ONLY with Carpuject Holders.

Hospira

PRINCIPAL DISPLAY PANEL - 1 mg/mL Cartridge Box

PRINCIPAL DISPLAY PANEL - 1 mg/mL Syringe Label

1 mL Single-use
NDC 0409-1283-09
Rx only

HYDROmorphone HCl
Injection, USP
1 mg/mL
CII

PROTECT FROM LIGHT

RL-4939

PRINCIPAL DISPLAY PANEL - 1 mg/mL Syringe Label - 6699

NDC 0409-1283-09
Rx only

iSecure™
SYRINGE

1 mL Single-use
Syringe with Luer Lock

HYDROmorphone HCl
Injection, USP
1 mg/mL
CII

PROTECT FROM LIGHT

Hospira, Inc.
Lake Forest, IL 60045 USA
Hospira

RL-6699

PRINCIPAL DISPLAY PANEL - 1 mg/mL Syringe Label - 6699

PRINCIPAL DISPLAY PANEL - 1 mg/mL Syringe Box

10 x 1 mL
Single-use Prefilled Syringe
with Luer Lock

NDC 0409-1283-10
Rx only

iSecure™
SYRINGE

HYDROmorphone HCl
Injection, USP
1 mg/mL
CII

For Intravenous, Intramuscular, or Subcutaneous Use

Hospira

PRINCIPAL DISPLAY PANEL - 1 mg/mL Syringe Box

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Label

0.5 mL Single-use
NDC 0409-1283-04
Rx only

HYDROmorphone HCl
Injection, USP
0.5 mg/0.5 mL
PROTECT FROM LIGHT
CII

RL-4937

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Label - 6698

NDC 0409-1283-04
Rx only

iSecure™
SYRINGE

0.5 mL Single-use
Syringe with Luer Lock

HYDROmorphone HCl
Injection, USP
0.5 mg/0.5 mL
CII

PROTECT FROM LIGHT

Hospira Inc.
Lake Forest, IL 60045 USA

Hospira

RL-6698

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Label - 6698

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Box

10 x 0.5 mL
Single-use Prefilled Syringe
with Luer Lock

NDC 0409-1283-05
Rx only

iSecure™
SYRINGE

HYDROmorphone HCl
Injection, USP
CII
0.5 mg/0.5 mL
Hospira

For Intravenous, Intramuscular, or Subcutaneous Use

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringe Box

PRINCIPAL DISPLAY PANEL - 2 mg/mL Cartridge Label

1 mL Single-use Carpuject™
Sterile Cartridge Unit with Luer Lock

NDC 0409-1312-03
Rx only

HYDROmorphone HCl
Injection, USP
2 mg/mL
CII

PROTECT FROM LIGHT
Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

RL-5554

PRINCIPAL DISPLAY PANEL - 2 mg/mL Cartridge Label

PRINCIPAL DISPLAY PANEL - 2 mg/mL Cartridge Box

1 mL
Single-use

NDC 0409-1312-30
Rx only

10 Carpuject™
Sterile Cartridge Units
with Luer Lock

Needle not included

SLIM-PAK™
Tamper Detection Package

HYDROmorphone HCl
Injection, USP
2 mg/mL
CII

For Intravenous,
Intramuscular, or
Subcutaneous Use

Carpuject Cartridges are to be used
ONLY with Carpuject Holders.

Hospira

PRINCIPAL DISPLAY PANEL - 2 mg/mL Cartridge Box

PRINCIPAL DISPLAY PANEL - 2 mg/mL Syringe Label

1 mL Single-use
NDC 0409-1312-09
Rx only

HYDROmorphone HCl
Injection, USP
2 mg/mL
CII

PROTECT FROM LIGHT

RL-4941

PRINCIPAL DISPLAY PANEL - 2 mg/mL Syringe Label - 6715

NDC 0409-1312-09
Rx only

iSecure™
SYRINGE

1 mL Single-use
Syringe with Luer Lock

HYDROmorphone HCl
Injection, USP
2 mg/mL
CII

PROTECT FROM LIGHT

Hospira, Inc.
Lake Forest, IL 60045 USA
Hospira

RL-6715

PRINCIPAL DISPLAY PANEL - 2 mg/mL Syringe Label - 6715

PRINCIPAL DISPLAY PANEL - 2 mg/mL Syringe Box

10 x 1 mL
Single-use Prefilled Syringe
with Luer Lock

NDC 0409-1312-10
Rx only

iSecure™
SYRINGE

HYDROmorphone HCl
Injection, USP
2 mg/mL
CII

Hospira

For Intravenous, Intramuscular, or Subcutaneous Use

PRINCIPAL DISPLAY PANEL - 2 mg/mL Syringe Box

PRINCIPAL DISPLAY PANEL - 4 mg/mL Cartridge Label

1 mL Single-use Carpuject™
Sterile Cartridge Unit with Luer Lock

NDC 0409-1304-03
Rx only

HYDROmorphone HCl
Injection, USP
4 mg/mL
CII

PROTECT FROM LIGHT

Hospira
Hospira, Inc.,
Lake Forest, IL 60045 USA

RL-5556

PRINCIPAL DISPLAY PANEL - 4 mg/mL Cartridge Label

PRINCIPAL DISPLAY PANEL - 4 mg/mL Cartridge Box

1 mL
Single-use

NDC 0409-1304-31
Rx only

10 Carpuject™
Sterile Cartridge Units
with Luer Lock

Needle not included

SLIM-PAK™
Tamper Detection Package

HYDROmorphone HCl
Injection, USP
4 mg/mL
CII

For Intravenous,
Intramuscular, or
Subcutaneous Use

Carpuject Cartridges are
to be used ONLY with
Carpuject Holders.

Hospira

PRINCIPAL DISPLAY PANEL - 4 mg/mL Cartridge Box

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

hydromorphone hydrochloride injection, USP Quick Finder

Ingredient & Allergen Checker
Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All